Skip to main content
James Mulshine, MD, Oncology, Chicago, IL

JamesMulshineMD

Oncology • Chicago, IL

Professor, Internal Medicine, Rush Medical College of Rush Univ

Join to view full profile

Dr. Mulshine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mulshine's full profile

Already have an account?

  • Office

    1725 W Harrison St
    Ste 1010
    Chicago, IL 60612
    Phone+1 301-980-6787

Summary

  • Dr. James Mulshine is an oncologist based in Chicago, IL, with a focus on thoracic, general medical, and endocrine oncology. He completed his internal medicine residency at Cleveland Clinic Foundation in 1980 and graduated from Loyola University Chicago Stritch School of Medicine in 1977. Dr. Mulshine completed Internal Medicine training at the Cleveland Clinic in 1980 and Medical Oncology training at the National Cancer Institute in 1982. He remand at Bethesda on the research faculty until 2005. He then moved to Rush University as Associate Provost and Vice President of Research and stayed on at Rush to the present time in a number of capacities.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1977 - 1980
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1977

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2005 - 2026
  • MD State Medical License
    MD State Medical License 1980 - 2007
  • OH State Medical License
    OH State Medical License 1978 - 1982
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Experts Urge Improved Patient Engagement to Increase CT Lung Screening Rates
    Experts Urge Improved Patient Engagement to Increase CT Lung Screening RatesDecember 6th, 2021
  • NSCLC Survival Improving in U.S.; Older Patients Undertreated
    NSCLC Survival Improving in U.S.; Older Patients UndertreatedOctober 28th, 2021
  • Is the 2021 USPSTF Lung Cancer Screening Guidance Cost-Effective?
    Is the 2021 USPSTF Lung Cancer Screening Guidance Cost-Effective?October 21st, 2021
  • Join now to see all

Dr. James Mulshine, Dr. James Mulshine, MD, Dr. J Mulshine